World's Best Scientists 2026 revealed!
Serge Gauthier

Serge Gauthier

D-Index & Metrics

Medicine

D-Index
127
Citations
95226
World Ranking
2763
National Ranking
108

Overview

Serge Gauthier is affiliated with McGill University in Canada, with a research focus primarily in the fields of Medicine and Neuroscience. Their scientific work encompasses several subfields including Psychiatry and Mental Health, Physiology, Neurology, Cognitive Neuroscience, and Radiology, Nuclear Medicine and Imaging.

The scientist's research covers various topics, notably Dementia and Cognitive Impairment Research, Alzheimer's Disease Research and Treatments, Functional Brain Connectivity Studies, Neuroinflammation and Neurodegeneration Mechanisms, Advanced Neuroimaging Techniques and Applications, Neurological Disease Mechanisms and Treatments, and Health Systems, Economic Evaluations, and Quality of Life.

Serge Gauthier has published extensively, contributing to multiple frequent publication venues such as Alzheimer s & Dementia, Brain Communications, Neurology, bioRxiv (Cold Spring Harbor Laboratory), and The Journal of Prevention of Alzheimer s Disease.

Some recent notable papers authored or co-authored by the scientist include:

  • Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts (2020, The Lancet Neurology)
  • Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology (2021, Acta Neuropathologica)
  • Dementia care during COVID-19 (2020, The Lancet)
  • Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum (2021, JAMA Neurology)
  • Microglial activation and tau propagate jointly across Braak stages (2021, Nature Medicine)

Their collaborative network features frequent co-authors such as Pedro Rosa-Neto, Tharick A. Pascoal, Joseph Therriault, Firoza Z Lussier, and Cécile Tissot, reflecting ongoing partnerships within the research community.

Best Publications

  • Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium

    I. G. McKeith;I. G. McKeith;D. W. Dickson;J. Lowe;M. Emre

  • Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

    Bruno Dubois;Howard H. Feldman;Claudia Jacova;Steven T. DeKosky

  • Mild cognitive impairment

    Serge Gauthier;Barry Reisberg;Michael Zaudig;Ronald C. Petersen

  • Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

    Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel

  • Clinical diagnostic criteria for dementia associated with Parkinson's disease.

    Murat Emre;Dag Aarsland;Dag Aarsland;Richard Brown;David J. Burn

  • SeminarAlzheimer's disease

    Clive Ballard;Serge Gauthier;Anne Corbett;Carol Brayne

  • Revising the definition of Alzheimer's disease: a new lexicon.

    Bruno Dubois;Howard H. Feldman;Howard H. Feldman;Howard H. Feldman;Claudia Jacova;Jeffrey L. Cummings

  • Vascular Cognitive Impairment

    John T O'Brien;Timo Erkinjuntti;Barry Reisberg;Gustavo Roman

  • Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

    Bruno Dubois;Harald Hampel;Harald Hampel;Howard H. Feldman;Philip Scheltens

  • Mild cognitive impairment: A concept in evolution

    Ronald C. Petersen;Barbara Caracciolo;Barbara Caracciolo;Carol Brayne;Serge Gauthier

  • Defeating Alzheimer's disease and other dementias: a priority for European science and society

    Bengt Winblad;Bengt Winblad;Philippe Amouyel;Sandrine Andrieu;Clive Ballard

  • Variable expression of Parkinson's disease A base‐line analysis of the DAT ATOP cohort

    Joseph Jankovic;Michael P McDermott;Jonathan T Carter;Susan A Gauthier

  • Prevalence and severity of cognitive impairment with and without dementia in an elderly population

    Janice E Graham;Kenneth Rockwood;B Lynn Beattie;Robin Eastwood

  • Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial.

    Michael Rösler;Ravi Anand;Ana Cicin-Sain;Serge Gauthier

  • Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.

    Thomas K. Karikari;Tharick A. Pascoal;Tharick A. Pascoal;Nicholas J. Ashton;Shorena Janelidze

  • Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.

    Michael Grundman;Ronald C. Petersen;Steven H. Ferris;Ronald G. Thomas

  • Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force

    Bruno Dubois;David Burn;Christopher Goetz;Dag Aarsland;Dag Aarsland

  • Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia.

    Isabelle Gélinas;Louise Gauthier;Maria McIntyre;Serge Gauthier

  • Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial

    Timo Erkinjuntti;Alexander Kurz;Serge Gauthier;Roger Bullock

  • A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease.

    H. Feldman;S. Gauthier;J. Hecker;B. Vellas

Frequent Co-Authors

Pedro Rosa-Neto
Pedro Rosa-Neto McGill University
Jean-Paul Soucy
Jean-Paul Soucy Montreal Neurological Institute and Hospital
Howard Feldman
Howard Feldman University of California, San Diego
Eduardo R. Zimmer
Eduardo R. Zimmer Federal University of Rio Grande do Sul
Sylvie Belleville
Sylvie Belleville University of Montreal
Bruno Vellas
Bruno Vellas Federal University of Toulouse Midi-Pyrénées
Sandra E. Black
Sandra E. Black University of Toronto
Kenneth Rockwood
Kenneth Rockwood Dalhousie University
Henrik Zetterberg
Henrik Zetterberg University of Gothenburg
Vladimir S. Fonov
Vladimir S. Fonov McGill University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online degrees can open up diverse career opportunities in the healthcare sector, even if you are considering or already studying Medicine in the USA. For those interested in healthcare leadership, an online healthcare administration degree provides skills in managing medical facilities, policy, and operations. This pathway is ideal for those looking to move into administrative roles within hospitals, clinics, or public health organizations.

Nurses seeking advanced practice roles can benefit from asn to nurse practitioner programs. These bridge programs help registered nurses fast-track their careers and take on more responsibility in patient care.

If you are passionate about diet, wellness, and disease prevention, pursuing nutrition degrees online may be the right fit. This pathway can lead to roles in nutrition counseling, community health programs, or food and wellness industries.

Finally, for those aiming for high-level healthcare management roles, consider top online mha programs that are cahme accredited. Accreditation ensures these master's programs meet national standards, preparing you for leadership in healthcare administration.

Best Scientists Citing Serge Gauthier

Trending Scientists